Five years after the FDA approved the first-ever prescription software to treat substance use disorder, the company behind the treatment has filed for bankruptcy protection and is on the verge of shutting down.
Five years after the FDA approved the first-ever prescription software to treat substance use disorder, the company behind the treatment has filed for bankruptcy protection and is on the verge of shutting down.
